Clinical Trials Browser

Phase 2 × Neoplasms × tazarotene × Clear all

NCT00489086 2020-10-29

Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Face

Phase 2 Completed

36 enrolled 7 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Neoplasms